Global Protein Engineering Market 2018-2023 - Analysis by Product Type, Technology, End-user, and Geography - ResearchAndMarkets.com

DUBLIN--()--The "Global Protein Engineering Market - Segmented By Product Type, Technology, End-user, and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.

The Protein Engineering Market is expected to witness a CAGR of 15.8% during the forecast period. The demand for protein engineering in developing countries is coupled with the preference of protein therapy over the gene therapy and expiry of top biologics drugs in the near future.

Many of the protein or peptide based drugs are being developed, and their quantity and frequency of usage has increased dramatically, for example, drugs like tissue plasminogen activator, human growth hormone, interleukin-2, and erythropoietin. Protein drugs have a high adoption rate in terms of size, molecular weight, formulation, delivery route, and therapeutic response. The peptide and protein drugs are also used in the treatment of the neurodegenerative diseases. The potential benefits of the protein drugs are immense, and the continued investment in developing therapeutic proteins or peptides is expected to be profitable in the long-run, which is ultimately driving the protein engineering market.

Other factors include increased demand for alternatives to chemical processes, increasing prevalence of protein deficient diseases, and the increase in government funding.

North America region is dominating the market which is being followed by Europe and APAC, regions due to the rising prevalence of lifestyle associated diseases and increasing adoption of protein based drugs in the regions. The Governments of the US, Canada, and Brazil have been highly supportive of advancements in protein engineering, creating a favorable regulatory environment for companies in the North American market. The Asia-Pacific region is also anticipated to grow with a decent CAGR in the upcoming years.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

  • Thermo Fisher Scientific
  • Eli Lilly and Company
  • Sigma-Aldrich Corporation
  • Perkinelmer Inc.
  • Bruker Corporation
  • Agilent Technologies
  • Bio-Rad Laboratories Inc.
  • Waters Corporation
  • Amgen
  • Novo Nordisk

10. Future of the market

For more information about this report visit https://www.researchandmarkets.com/research/g8rrcn/global_protein?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Proteomics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Proteomics